Cho, Y. K., Kim, Y., Kang, Y. M., Lee, S. E., Park, J., Lee, W. J., & Jung, C. H. (2018). Comparison between sodium–glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta‐analysis. Journal of diabetes investigation, 9(4), 882-892. https://doi.org/10.1111/jdi.12787
Chicago Style (17th ed.) CitationCho, Yun Kyung, Ye‐Jee Kim, Yu Mi Kang, Seung Eun Lee, Joong‐Yeol Park, Woo Je Lee, and Chang Hee Jung. "Comparison Between Sodium–glucose Cotransporter 2 Inhibitors and Pioglitazone as Additions to Insulin Therapy in Type 2 Diabetes Patients: A Systematic Review with an Indirect Comparison Meta‐analysis." Journal of Diabetes Investigation 9, no. 4 (2018): 882-892. https://doi.org/10.1111/jdi.12787.
MLA (9th ed.) CitationCho, Yun Kyung, et al. "Comparison Between Sodium–glucose Cotransporter 2 Inhibitors and Pioglitazone as Additions to Insulin Therapy in Type 2 Diabetes Patients: A Systematic Review with an Indirect Comparison Meta‐analysis." Journal of Diabetes Investigation, vol. 9, no. 4, 2018, pp. 882-892, https://doi.org/10.1111/jdi.12787.